Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
Resmed Inc, a company listed on the NYSE, has filed a Form 144 for the proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing indicates that Jan De Witte, a director of the company, plans to sell 2,055 shares of common stock, with an aggregate market value of $524,025. The shares were acquired through restricted stock vesting, with the sale expected to occur on November 25, 2025. This transaction reflects ongoing insider trading activities and may have implications for the company’s stock liquidity and market perception.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,211,977
Technical Sentiment Signal: Buy
Current Market Cap: A$56.58B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.